Case series of thrombotic thrombocytopenic purpura in children and adolescents

Journal of Pediatric Hematology/Oncology

Volumn 25, Issue 4, 2003, Pages 336-339

  Horton, Terzah M ^a   Stone, Jeffrey D ^a   Yee, Donald ^a   Dreyer, ZoAnn ^a   Moake, Joel L ^b   Mahoney, Donald H ^a,c  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c TEXAS CHILDREN S CANCER CENTER   (United States)

Author keywords

Children; Thrombocytopenia; Thrombosis; TTP

Indexed keywords

PROTEINASE INHIBITOR; VON WILLEBRAND FACTOR;

ADOLESCENT; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR ACCIDENT; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DIARRHEA; DIFFERENTIAL DIAGNOSIS; ENZYME ACTIVITY; FEMALE; FEVER; HEMATURIA; HEMIPARESIS; HUMAN; JAUNDICE; KIDNEY FAILURE; MALE; MENTAL DEFICIENCY; PETECHIA; PLASMA TRANSFUSION; PLASMAPHERESIS; PRIORITY JOURNAL; PURPURA; RELAPSE; SEIZURE; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; ADOLESCENT; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BLOOD COMPONENT TRANSFUSION; CEREBRAL HEMORRHAGE; CHILD; CHILD, PRESCHOOL; CONSCIOUSNESS DISORDERS; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INFANT; KIDNEY TUBULAR NECROSIS, ACUTE; MALE; METALLOENDOPEPTIDASES; PARESIS; PLASMA; PLASMA EXCHANGE; PURPURA, THROMBOTIC THROMBOCYTOPENIC; TEXAS; THYROIDITIS, AUTOIMMUNE;

EID: 0037397410     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200304000-00016     Document Type: Article

References (23)

1. Moake JL. Studies on the pathophysiology of thrombotic thrombocytopenic purpura. Semin Hematol 1997;34:83-9.
2. George JN. How 1 treat patients with thrombotic thrombocytopenic purpurahemolytic uremic syndrome. Blood 2000;96:1223-9.
3. Cines DB, Konkle BA, Furlan M. Thrombotic thrombocytopenic purpura: a paradigm shift? Thromb Haemost 2000;84:528-35.
4. Moake JL, McPherson PD. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Am J Med 1989;87:9N-15N.
5. Chintagumpala MM, Hurwitz RL, Moake JL, et al. Chronic relapsing thrombotic thrombocytopenic purpura in infants with large von Willebrand factor multimers during remission. J Pediatr 1992;120:49-53.
6. Furlan M, Robles R, Galbusera M, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998;339:1578-84.
7. Chow TW, Turner NA, Chintagumpala M, et al. Increased von Willebrand factor binding to platelets in single-episode and recurrent types of thrombotic thrombocytopenic purpura. Am J Hematol 1998;57:293-302.
8. Gerritsen HE, Robles R, Lammle B, et al. Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood 2001;98:1654-61.
9. Fujikawa K, Suzuki H, McMullen B, et al. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood 2001;98:1662-6.
10. Levy GG, Nichols WC, Lian EC, et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001;413:488-94.
11. Sartori PC, Enayat MS, Darbyshire PJ. Congenital microangiopathic haemolytic anemia: a variant of thrombotic thrombocytopenic purpura? Pediatr Hematol Oncol 1993;10:271-7.
12. Daghistani D, Jimenez JJ, Moake JL, et al. Familial infantile thrombotic thrombocytopenic purpura. J Pediatr Hematol Oncol 1996;18:171-4.
13. Furlan M, Robles R, Solenthaler M, et al. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood 1997;89:3097-103.
14. Moake JL, Rudy CK, Troll JH, et al. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 1982;307:1432-5.
15. Budde U, Schneppenheim R, Plendl H. et al. Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes. Thromb Haemost 1990;63:312-5.
16. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998;339:1585-94.
17. Fessler BJ. Thrombotic syndromes and autoimmune diseases. Rheum Dis Clin North Am 1997;23:461-79.
18. Mannucci PM, Canciani MT, Forza I, et al. Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood 2001;98:2730-5.
19. Moore JC, Hayward CP, Warkentin TE, et al. Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders. Blood 2001;98:1842-6.
20. Savasan S, Taub JW, Buck S, et al. Congenital microangiopathic hemolytic anemia and thrombocytopenia with unusually large von Willebrand factor multimers and von Willebrand factor-cleaving protease. J Pediatr Hematol Oncol 2001;23:364-7.
21. Piastra M, Curro V, Chiaretti A, et al. Intracranial hemorrhage at the onset of thrombotic thrombocytopenic purpura in an infant: therapeutic approach and intensive care management. Pediatr Emerg Care 2001;17:42-5.
22. Lawlor ER, Webb DW, Hill A, et al. Thrombotic thrombocytopenic purpura: a treatable cause of childhood encephalopathy. J Pediatr 1997;130:313-6.
23. Krupsky M, Sarel R, Hurwitz N, et al. Late appearance of thrombotic thrombocytopenic purpura after autoimmune hemolytic anemia and in the course of chronic autoimmune thrombocytopenic purpura: two case reports. Acta Haematol 1991;85:139-42.